Skin and alcohol;Haut und alkohol

JDDG - Journal of the German Society of Dermatology

Volumn 3, Issue 10, 2005, Pages 788-809

  Vogl, Annegret ^a   Landthaler, Michael ^a   Vogt, Thomas ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETALDEHYDE; ALCOHOL; ALDEHYDE DEHYDROGENASE; CATALASE; XANTHINE OXIDASE;

ACNE VULGARIS; ALCOHOL CONSUMPTION; FETAL ALCOHOL SYNDROME; FLUSHING; HUMAN; IMMUNE SYSTEM; MELANOMA; PATHOPHYSIOLOGY; PORPHYRIA CUTANEA TARDA; PSORIASIS VULGARIS; REVIEW; ROSACEA; SEBORRHEIC DERMATITIS; SKIN; ADOLESCENT; ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ALCOHOLIC PANCREATITIS; ALCOHOLISM; CROSS-SECTIONAL STUDY; DISEASE COURSE; FEMALE; GERMANY; MALE; MIDDLE AGED; SKIN DISEASE; SKIN TUMOR;

ADOLESCENT; ADULT; AGED; ALCOHOLISM; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; ETHANOL; FEMALE; GERMANY; HUMANS; LIVER CIRRHOSIS, ALCOHOLIC; MALE; MIDDLE AGED; PANCREATITIS, ALCOHOLIC; SKIN DISEASES; SKIN NEOPLASMS;

EID: 33644681988     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2005.05537.x     Document Type: Review

References (108)

1. Rosengren A, Wilhelmsen L, Wedel H. Separate and combined effects of smoking and alcohol abuse in middle-aged men. Acta Med Scand 1988; 223: 111-118.
2. Bader U, Hafner J, Burg G. Erythrodermie und Ethylabusus. Schweiz Med Wochenschr 1999; 129: 508-513.
3. Pöschl G, Seitz HK. Alcohol and cancer. Alcohol 2004; 39: 155-165.
4. Friedman H, Newton C, Klein TW. Microbial infections, immunmodulation, and drugs of abuse. Clin Microbiol Rev 2003; 16: 209-219.
5. Lawlor MT, Crowe HM, Quintiliani R. Cellulitis due to Streptococcus pneumonie: Case report and review. Clin Infect Dis 1992; 14: 247-250.
6. Wang Y, Watson RR. Chronic ethanol consumption before retrovirus infection is a cofactor in the development of immune dysfunction during murine AIDS. Alcohol Clin Exp Res 1994; 18: 976-981.
7. Szabo G, Catalano D, White B, Mandrekar P. Acute alcohol consumption inhibits accessory cell function of monocytes and dendritic cells. Alcohol Clin Exp Res 2004; 28: 824-828.
8. Cook RT, Garvey MJ, Booth BM, Goehen JA, Stewart B, Noel M. Activated CD-8 cells and HLA DR expression in alcoholics without ouvert liver disease. J Clin Immun 1991; 11: 246-253.
9. Burg G, Kettelhack N. Haut und Alkohol. Dtsch Arztebl 2002; 99: 2712-2311.
10. Kaufmann R. Haut und Alkohol. In: Plewig et al., Fortschritte der praktischen Dermatologie und Venerologie 2004; 1. Auflage, Springer Verlag: 150-154.
11. Foutch PG, Sullivan JA, Gaines JA. Cutaneous vascular spiders in cirrhotic patients: correlation with hemorrhage from esophageal varices. Am J Gastroenterol 1988; 83: 723-726.
12. Shellow WV. The skin in alcoholism. Int J Dermatol 1983; 22: 506-510.
13. Godtfredsen NS, Lucht H, Prescott E, Soerensen TIA, Groenbaek M. A prospective study linked both alcohol and tobacco to Dupuytrens's disease. Clin Epidemiol 2004; 57: 858-863.
14. Miller SJ. Nutritional deficiency and the skin. J Am Acad Dermatol 1989; 21: 1-30.
15. Poikolainen K, Reunala T, Karvonen J. Smoking, alcohol and life events related to psoriasis among women. Br J Dermatol 1994; 130: 473-477.
16. Gupta MA, Schork NJ, Gupta AK, Ellis CN. Alcohol intake and treatment responsiveness of psoriasis: a prospective study. J Am Acad Dermatol 1993; 28: 730-732.
17. Golik-Gruber V, Buljan D. Rosacea-Cutaneous Stigmata of Alcoholism. Acta Derm Venerol 2004; 12: 210.
18. Parish LC, Fine E. Alcoholism and skin disease. Int J Dermatol 1985; 24: 300-301.
19. Sticherling M, Brasch J. Alcohol: Intolerance syndromes, urticarial and anaphylactoid reactions. Clin Dermatol 1999; 17: 417-422.
20. Przybilla B, Ring J. Anaphylaxis to ethanol and sensitization to acetic acid. Lancet 1983; 26: 483.
21. Holman CD, Armstrong BK, Heenan PJ, Blackwell JB, Cumming FJ, English DR, Holland S, Kelsall GR, Matz LR, Rouse IL. The causes of malignant melanoma: results from the West Australian Lions Melanoma Research Project. Recent Results Cancer Res 1986; 102: 18-37.
22. Kune GA, Bennerman S, Field B, Watson LF, Cleland H, Merenstein D, Vitetta L. Diet, alcohol, smoking, serum-beta-carotene, and vitamin A in male nonmelanotic skin cancer patients and controls. Nutr Cancer 1992; 18: 237-244.
23. Oram Y, Orengo I, Griego RD, Rosen T, Thornby J. Histologic patterns of basal cell carcinoma based upon patient immunostatus. Dermatol Surg 1995; 21: 611-614.
24. Elder GH. Alcohol intake and porphyria cutanea tarda. Clin Dermatol 1999; 17: 431-436.
25. Ruzicka T, Vieluf D, Landthaler M, Braun-Falco O. Benign symmetric lipomatosis Launois-Bensaude. Report often cases and review of the literature. J Am Acad Dermatol 1987; 17: 6663-6674.
26. Thoma E, Ruzicka T, Donhauser G, Albrecht T, Braun-Falco O. Clinical aspects and therapy of Bureau-Barrière syndrome. Observations of 17 cases with review of the literature. Hautarzt 1993; 44: 5-13.
27. Spohr HL, Wilms J, Steinhausen HC. Prenatal alcohol exposure and longterm developmental consequences. Lancet 1993; 341: 907-910.
28. Soleas GJ et al. A comparison of the anticarcinogenic properties of four red wine polyphenols. Clinical Biochemistry 2002; 35: 119-124.
29. Mukamal KJ et al. Prospective study of alcohol consumption and risk of dementia in older adults. JAMA 2003; 289: 1405-1413.
30. Rumpf HJ, Meyer C. Inanspruchnahme suchtspezifischer Hilfen von Alkoholabhängigen und -missbrauchern: Ergebnisse der TACOS Bevölkerungsstudie. Sucht 2000; 46: 9-17.
31. Lieb R et al. Epidemiologie des Konsums, Missbrauchs und der Abhängigkeit von legalen und illegalen Drogen bei Jugendlichen und jungen Erwachsenen: die prospektiv-longitudinale Verlaufsstudie EDSP. Sucht 2000; 46: 18-31.
32. Rosengren A et al. Separate and combined effects of smoking and alcohol abuse in middle-aged men. Acta Med Scand 1988; 223: 111-118.
33. Paton A. Alcohol in the body. BMJ 2005; 330: 85-87.
34. Pöschl G, Seitz HK. Alcohol and cancer. Alcohol Alcohol 2004; 39: 155-165.
35. Friedman H et al. Microbial infections, immunmodulation, and drugs of abuse. Clin Microbiol Rev 2003; 16: 209-219.
36. Messingham KAN et al. Alcohol, injury, and cellular immunity. Alcohol 2002; 28: 137-149.
37. McGill V et al. The impact of substance use on mortality and morbidity from thermal injury. J Trauma 1995; 38: 931-934.
38. Skogberg K et al. Beta-haemolytic group A, B, C and G streptococcal septicaemia: a clinical study. Scand J Inf Dis 1988; 20: 119-125.
39. Mehregan DA et al. Cutaneous botrymycosis. J Am Acad Dermatol 1991; 24: 393-396.
40. Harnisch JP et al. Diphteria among alcoholic urban adults. A decade of experience in Seattle. Ann Intern Med 1989; 111: 71-82.
41. Lawlor MT et al. Cellulitis due to Streptococcus pneumonie: Case report and review. Clin Infect Dis 1992; 14: 247-250.
42. Cook RT et al. Increased prevalence of herpes simplex virus typ 2 among adolescent young woman with alcohol use disorders. J Adolesc Health 2002; 30: 169-174.
43. Wang Y, Watson RR. Chronic ethanol consumption before retrovirus infection is a cofactor in the development of immune dysfunction during murine AIDS. Alcohol Clin Exp Res 1994; 18: 976-981.
44. Sanchez MR. Alcohol, social behavior disorders, and their cutaneous manifestations. Clin Dermatol 1999; 17: 479-489.
45. Castrejon OV et al. Fatal fungemia due to Sporothrix schenckii. Mycoses 1995; 38: 373-376.
46. Bautista AP. Free radicals, chemokines, and cell injury in HIV-1 and SIV infections and alcoholic hepatitis. Free Radic Biol Med 2001; 31: 1527-1532.
47. Szabo G et al. Acute alcohol consumption inhibits accessory cell function of monocytes and dendritic cells. Alcohol Clin Exp Res 2004; 28: 824-828.
48. Mandrekar P et al. Inhibition of myeloid dendritic cell accessory cell function and induction of T cell anergy by alcohol correlates with decreased IL-12 production. Immunol 2004; 173: 3398-3407.
49. Cook RT et al. Activated CD-8 cells and HLA DR expression in alcoholics without ouvert liver disease. J Clin Immun 1991; 11: 246-253.
50. Rook AH et al. Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. Immunol 1986; 136: 3916-3920.
51. Zhang Z et al. Inhibition of TNF-a processing and TACE-mediated ectodomain shedding by ethanol. J Leukoc Biol 2000; 67: 856-862.
52. Burg G, Kettelhack N. Haut und Alkohol. Dtsch Arztebl 2002; 99: 2712-2311.
53. Kaufmann R. Haut und Alkohol. In: Plewig et al., Fortschritte der praktischen Dermatologie und Venerologie 2004; 1. Auflage, Springer Verlag: 150-154.
54. Foutch PG et al. Cutaneous vascular spiders in cirrhotic patients: correlation with hemorrhage from esophageal varices. Am J Gastroenterol 1988; 83: 723-726.
55. Grosshans EM, LeCoz CJ. Alcohol intake, lipid metabolism, and the skin. Clin Dermatol 1999; 17: 413-416.
56. Ruocco V et al. Dermatological manifestations of alcoholic cirrhosis. Clin Dermatol 1999; 17: 463-468.
57. Lawrence CM et al. Plasma bile salt levels in patients presenting with generalised pruritus: an improved indicator of occult liver disease. Ann Clin Biochem 1985; 22: 232-235.
58. Shellow WV. The skin in alcoholism. Int J Dermatol 1983; 22: 506-510.
59. Godtfredsen NS et al. A prospective study linked both alcohol and tobacco to Dupuytrens's disease. Clin Epidemiol 2004; 57: 858-863.
60. Bystrom J. Induration penis plastica. Experience of treatment with procarbazine Natulan. Scand J Urol Nephrol 1976; 10: 21-25.
61. Miller SJ. Nutritional deficiency and the skin. J Am Acad Dermatol 1989; 21: 1-30.
62. Topham EJ, Child FJ. Exfoliative erythema of malnutrition with zinc and essential amino acid deficiency. Clin Exp Dermatol 2005; 30: 235-237.
63. Chaput JC et al. Psoriasis, alcohol and liver disease. Br Med J (Clin Res Ed) 1985; 291: 25.
64. Braathen LR et al. Psoriatics in Norway: a questionnaire study on health status, contact with paramedical professions, and alcohol and tobacco consumption. Acta Derm Venerol Suppl (Stockh) 1989; 142: 9-12.
65. Zamboni S et al. Dietary behavior in psoriatic patients. Acta Derm Venerol Suppl (Stockh) 1989; 146: 182-183.
66. Poikolainen K et al. Smoking, alcohol and life events related to psoriasis among women. Br J Dermatol 1994; 130: 473-477.
67. Duffy DL et al. Psoriasis in Australian twins. J Am Acad Dermatol 1993; 29: 428-434.
68. Naldi L et al. Family history, smoking habits, alcohol consumption and risk of psoriasis. Br J Dermatol 1992; 127: 212-217.
69. Poikolainen K et al. Alcohol intake: A risk factor for psoriasis in young and middle-aged men? BMJ 1990; 300: 780-783.
70. Gupta MA et al. Alcohol intake and treatment responsiveness of psoriasis: a prospective study. J Am Acad Dermatol 1993; 28: 730-732.
71. Vincenti GE, Blunden SM. Psoriasis and alcohol abuse. J R Army Med Corps 1987; 133: 77-78.
72. Wolf R et al. Alcohol intake and psoriasis. Clin Dermatol 1999; 17: 423-430.
73. Ockenfels HM et al. Ethanol enhances the IFN-gamma, TGF-a and IL-6 secretion in psoriatic co-cultures. Br J Dermatol 1996; 135: 746-751.
74. Schopf RE et al. Ethanol enhances the mitogen-driven lymphocyte proliferation in patients with psoriasis. Acta Derm Venerol 1996; 76: 260-263.
75. Crawford GH et al. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 2004; 51: 327-341.
76. Golik-Gruber V, Buljan D. Rosacea-Cutaneous Stigmata of Alcoholism. Acta Derm Venerol 2004; 12: 210.
77. Hook-Nikanne J et al. Could bacterial acetaldehyde production explain the deleterious effect of alcohol on skin diseases? Acta Derm Venerol 1995; 75: 330.
78. Parish LC, Fine E. Alcoholism and skin disease. Int J Dermatol 1985; 24: 300-301.
79. Mills CM, Marks R. Environmental factors influencing rosacea. Clin Exp Dermatol 1996; 21: 172-173.
80. Rosset M, Oki G. Skin diseases in alcoholics. QJ Stud Alcohol 1971; 32: 1017-1024.
81. Higgins EM, DuVivier A. Alcohol abuse and treatment resistance in skin disease. J Am Acad Dermatol 1994; 30: 1048.
82. Sticherling M, Brasch J. Alcohol: Intolerance syndromes, urticarial and anaphylactoid reactions. Clin Dermatol 1999; 17: 417-422.
83. Yokoyama A et al. Reliability of a flushing questionnaire and the ethanol patch test in screening for inactive aldehyde dehydrogenase-2 and alcohol-related cancer risk. Cancer Epidemiol Biomarkers Prev 1997; 1105-1107.
84. Ehlers I et al. Ethanol as a cause of hypersensitivity reactions to alcoholic beverages. Clin Exp Allergy 2002; 32: 1231-1235.
85. Przybilla B, Ring J. Anaphylaxis to ethanol and sensitization to acetic acid. Lancet 1983; 26: 483.
86. Wantke F et al. Adverse reactions to alcoholic beverages: a diagnostic guideline. Clin Exp Allergy 1997; 27: 343.
87. Jarisch R, Wantke F. Wine and headache. Int Arch Allergy Immunol 1996; 110: 7-12.
88. Osterlind A et al. The Danish case controll study of cutaneous malignant melanoma. IV. No association with nutritional factors, alcohol, smoking or hair dyes. Int J Cancer 1988; 42: 825-828.
89. Adami HO et al. Alcoholism and cancer risk: a population based cohort study. Cancer Causes Control 1992; 3: 419-425.
90. Holman CD et al. The causes of malignant melanoma: results from the West Australian Lions Melanoma Research Project. Recent Results Cancer Res 1986; 102: 18-37.
91. Stryker WS et al. Diet, plasma levels of beta-carotene and alpha-tocopherol, and risk of malignant melanoma. Am J Epidemiol 1990; 131: 597-611.
92. Millen AE et al. Diet and melanoma in a case-control study. Cancer Epidemiol Biomarkers Prev 2004; 13: 1042-1051.
93. Williams RR. Breast and thyroid cancer and malignant melanoma promoted by alcohol-induced pituitary secretion of prolactin, TSH and MSH. Lancet 1976; 1: 996-999.
94. Graham S et al. Dentition, diet, tobacco, and alcohol in the epidemiology of oral cancer. J Natl Cancer Inst 1977; 59: 1611-1618.
95. Ng SKC et al. Oral cavity cancer in non-users of tobacco. J Natl Cancer Inst 1993; 85: 743-745.
96. Longnecker MP. Alcohol consumption and the risk of cancer in humans: An overview. Alcohol 1995; 12: 87-96.
97. Kune GA et al. Diet, alcohol, smoking, serum-beta-carotene, and vitamin A in male nonmelanotic skin cancer patients and controls. Nutr Cancer 1992; 18: 237-244.
98. Sahl WJ et al. Basal cell carcinoma and lifestyle characteristics. Int J Dermatol 1995; 34: 398-402.
99. Milan T et al. Lifestyle differences in twin pairs discordant for basal cell carcinoma of the skin. Br J Dermatol 2003; 149: 115-123.
100. Oram Y et al. Histologic patterns of basal cell carcinoma based upon patient immunostatus. Dermatol Surg 1995; 21: 611-614.
101. Elder GH. Alcohol intake and porphyria cutanea tarda. Clin Dermatol 1999; 17: 431-436.
102. Mukerji SK. Haem biosynthesis and human porphyria cutanea tarda: effects of alcohol intake. Indian J Exp Biol 2000; 38: 635-642.
103. Dahl PR et al. Pancreatic panniculitis. J Am Acad Dermatol 1995; 33: 413-417.
104. Ruzicka T et al. Benign symmetric lipomatosis Launois-Bensaude. Report of ten cases and review of the literature. J Am Acad Dermatol 1987; 17: 6663-6674.
105. González-Garcia R et al. Benign symmetric lipomatosis (Madelung's disease): case reports and current management. Aesthetic Plast. Surg. 2004; 28: 108-112.
106. Thoma E et al. Clinical aspects and therapy of Bureau-Barrière syndrome. Observations of 17 cases with review of the literature. Hautarzt 1993; 44: 5-13.
107. Shibley IAJ, Pennington SN. Metabolic and mitotic changes associated with the fetal alcohol syndrome. Alcohol Alcohol 1997; 32: 423-434.
108. Spohr HL et al. Prenatal alcohol exposure and longterm developmental consequences. Lancet 1993; 341: 907-910.